Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Quidel Corporation    QDEL

QUIDEL CORPORATION

(QDEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nevada's prohibition of Quidel, Becton Dickinson's COVID-19 tests violates law - HHS official

10/09/2020 | 01:56pm EST

Oct 9 (Reuters) - U.S. state of Nevada's recent ban on the use of Quidel Corp's Sofia and Becton Dickinson and Co's (BD) Veritor point of care antigen tests in long-term care facilities violates federal law, a U.S. government official said on Friday.

"The letter (on ban) from Nevada officials can only be interpreted as reflecting a fundamental lack of basic knowledge about testing and interpreting results," said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services, in a press briefing. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ADMIRAL GROUP PLC 0.35% 2857 Delayed Quote.23.73%
BECTON, DICKINSON AND COMPANY 2.57% 234.84 Delayed Quote.-13.65%
QUIDEL CORPORATION 3.75% 195.05 Delayed Quote.159.96%
All news about QUIDEL CORPORATION
11/19QUIDEL CORPORATION : Hosts Upcoming Webinar to Help Health Professionals Disting..
BU
11/13QUIDEL CORP /DE/ : Entry into a Material Definitive Agreement, Amendments to Art..
AQ
11/10QUIDEL : to Present at Upcoming Conferences
BU
11/10QUIDEL CORPORATION : Triple Winner in International MarCom Awards Competition
BU
11/07Many Nursing Homes Shun Free Covid-19 Testing Equipment
DJ
11/03QUIDEL : to Host Virtual Investor Day on November 12, 2020
BU
11/03QUIDEL : U.S. FDA warns about false positive results from COVID-19 antigen tests
RE
10/30QUIDEL : DE/ Management's Discussion and Analysis of Financial Condition and Res..
AQ
10/29QUIDEL : 3Q Earnings Snapshot
AQ
10/29QUIDEL CORP /DE/ : Results of Operations and Financial Condition, Financial Stat..
AQ
More news
Financials (USD)
Sales 2020 1 657 M - -
Net income 2020 773 M - -
Net cash 2020 150 M - -
P/E ratio 2020 11,0x
Yield 2020 -
Capitalization 8 205 M 8 205 M -
EV / Sales 2020 4,86x
EV / Sales 2021 1,95x
Nbr of Employees 1 250
Free-Float 88,2%
Chart QUIDEL CORPORATION
Duration : Period :
Quidel Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUIDEL CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 302,00 $
Last Close Price 195,05 $
Spread / Highest target 90,2%
Spread / Average Target 54,8%
Spread / Lowest Target -10,3%
EPS Revisions
Managers
NameTitle
Douglas C. Bryant President, Chief Executive Officer & Director
Kenneth F. Buechler Chairman
Robert Joseph Bujarski Chief Operating Officer
Randall J. Steward Chief Financial Officer
Werner Kroll Senior Vice President-Research & Development
Sector and Competitors